L. Zucchi

发表

Long-term benefits of omalizumab in a patient with severe non-allergic asthma

A. Simonazzi, F. Menzella, N. Facciolongo, 2011, Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology.

Lymphangioleiomyomatosis associated with pulmonary metastasis from an occult papillary carcinoma of the thyroid: report of a case occurring in a patient without tuberous sclerosis.

G. Rossi, A. Cavazza, M. Zini, 2002, Pathology, research and practice.

Real-life Efficacy of Omalizumab After 9 Years of Follow-up

C. Galeone, D. Formisano, A. Simonazzi, 2017, Allergy, asthma & immunology research.

An unusual diagnosis of increasing respiratory failure after lung resection

T. Grimaldi, C. Rapicetta, F. Lococo, 2014, Internal and Emergency Medicine.

Recurrent lung atelectasis from fibrin plugs as a very early complication of bronchial thermoplasty: a case report

C. Galeone, A. Cavazza, M. Lusuardi, 2015, Multidisciplinary Respiratory Medicine.

Clinical Audit on Diagnostic Accuracy and Management of Respiratory Failure in COPD

D. Formisano, A. Simonazzi, M. Lusuardi, 2012, Respiratory Care.

Clinical and pharmacoeconomic aspects of omalizumab: a 4-year follow-up

D. Formisano, A. Simonazzi, F. Menzella, 2012, Therapeutic advances in respiratory disease.

Eosinophilic infiltrate in a patient with severe Legionella pneumonia as a levofloxacin-related complication: a case report

A. Cavazza, F. Menzella, N. Facciolongo, 2010, Journal of medical case reports.

Evaluation of a western blot serum test for the diagnosis of Mycobacterium tuberculosis infection.

M. Amicosante, C. Saltini, G. Angarano, 1996, The European respiratory journal.

Levels of circulating endothelial cells are low in idiopathic pulmonary fibrosis and are further reduced by anti-fibrotic treatments

L. Richeldi, G. Sgalla, C. Vancheri, 2015, BMC Medicine.

The clinical profile of benralizumab in the management of severe eosinophilic asthma

C. Galeone, M. Lusuardi, F. Menzella, 2016, Therapeutic advances in respiratory disease.

Mepolizumab for severe refractory eosinophilic asthma: evidence to date and clinical potential

C. Galeone, M. Lusuardi, F. Menzella, 2016, Therapeutic advances in chronic disease.

Clinical usefulness of mepolizumab in severe eosinophilic asthma

C. Galeone, M. Lusuardi, F. Menzella, 2016, Therapeutics and clinical risk management.

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

C. Galeone, M. Lusuardi, F. Menzella, 2015, Journal of asthma and allergy.

Tailored therapy for severe asthma

Mirco Lusuardi, C. Galeone, M. Lusuardi, 2015, Multidisciplinary Respiratory Medicine.

Endobronchial Hamartoma Subtotally Occluding the Right Main Bronchus and Mimicking Bronchial Carcinoid Tumor

C. Galeone, F. Lococo, C. Carbonelli, 2016, Medicine.

Pulmonary involvement in an adult female affected by type B Niemann Pick disease.

B. Bembi, A. Cavazza, M. G. Pittis, 2005, Sarcoidosis, vasculitis, and diffuse lung diseases : official journal of WASOG.

Endobronchial ultrasound-guided transbronchial needle aspiration under conscious sedation with meperidine and midazolam.

C. Galeone, M. Lusuardi, N. Facciolongo, 2017, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Relapsing bronchiolitis obliterans organising pneumonia and chronic sarcoidosis in an atopic asthmatic patient.

M. Zompatori, A. Cavazza, C. Carbonelli, 2008, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Omalizumab: when the non-responder is a late-responder.

A. Simonazzi, F. Menzella, N. Facciolongo, 2009, European annals of allergy and clinical immunology.

The effect of bronchial thermoplasty on nerve C-fibers and inflammatory cells in patients with severe asthma

B. Balbi, C. Galeone, V. Pietrini, 2015 .

Sarcoidosis and multiple sclerosis: systemic toxicity associated with the use of interferon-beta therapy.

A. Cavazza, F. Menzella, C. Carbonelli, 2012, Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace.

Profile of anti-IL-5 mAb mepolizumab in the treatment of severe refractory asthma and hypereosinophilic diseases

C. Galeone, M. Lusuardi, F. Menzella, 2015, Journal of asthma and allergy.